Caitlin Cronin Analyst Performance

Director - MedTech Equity Research at Canaccord Genuity Group

Caitlin Cronin is a stock analyst at Canaccord Genuity Group in the medical sector, covering 9 publicly traded companies. Over the past year, Caitlin Cronin has issued 16 stock ratings, including buy and hold recommendations. While full access to Caitlin Cronin's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Caitlin Cronin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 16 Last 0 Years
Buy Recommendations: 68.75% 11 Buy Ratings
Companies Covered: 9 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	68.8%	11 ratings
Hold	31.3%	5 ratings
Sell	0.0%	0 ratings

Out of 16 total stock ratings issued by Caitlin Cronin at Canaccord Genuity Group, the majority (68.8%) have been Buy recommendations, followed by 31.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	66.7% of companies on NASDAQ	6 companies
NYSE	33.3% of companies on NYSE	3 companies

Caitlin Cronin, an analyst at Canaccord Genuity Group, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 9 companies	100.0%

Caitlin Cronin of Canaccord Genuity Group specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED PRODUCTS 2 companies	22.2%
MED INSTRUMENTS 2 companies	22.2%
MED - BIOMED/GENE 2 companies	22.2%
MEDICAL SERVICES 1 company	11.1%
MEDICAL INFO SYS 1 company	11.1%
SURGICAL & MEDICAL INSTRUMENTS 1 company	11.1%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ESTA Establishment Labs	8/20/2025	Initiated Coverage	$37.70	$60.00	Buy
SNN Smith & Nephew SNATS	8/18/2025	Boost Price Target	$36.20	$36.00	Hold
ENOV Enovis	8/8/2025	Lower Price Target	$28.49	$58.00	Buy
ATEC Alphatec	8/1/2025	Reiterated Rating	$13.51	$20.00	Buy
VCEL Vericel	8/1/2025	Lower Price Target	$35.63	$58.00	Buy
INMD InMode	7/11/2025	Reiterated Rating	$14.78	$15.00	Hold
ENOV Enovis	5/14/2025	Lower Price Target	$36.07	$70.00	Buy
AXGN AxoGen	5/13/2025	Lower Price Target	$11.27	$24.00	Buy
SNN Smith & Nephew SNATS	5/1/2025	Boost Price Target	$28.26	$28.00	Hold
INMD InMode	4/29/2025	Lower Price Target	$14.26	$15.00	Hold
TELA TELA Bio	3/21/2025	Lower Price Target	$1.43	$7.00	Buy
SNN Smith & Nephew SNATS	3/17/2025	Reiterated Rating	$28.86	$27.00	Hold
BVS Bioventus	3/17/2025	Reiterated Rating	$9.71	$15.00	Buy
AXGN AxoGen	2/26/2025	Boost Price Target	$19.70	$26.00	Buy
VCEL Vericel	2/3/2025	Boost Price Target	$58.54	$67.00	Buy
AXGN AxoGen	2/3/2025	Boost Price Target	$18.21	$22.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.